Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 205
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04975711 | Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of HIP2105 to RLD2104 in Healthy Volunteers | ||
| NCT05199129 | Clinical Efficacy and Safety Evaluation of HCP1904-3 in Essential Hypertension Patients | ||
| NCT04946903 | A Study to Evaluate the Pharmacokinetics and Safety Between HCP1902 and Co-administration of RLD2007, RLD2008 | ||
| NCT03374241 | A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM15211(Efocipegtrutide) | ||
| NCT04039724 | Pharmacokinetics of HCP1305 and Co-administration of HCP0605, HGP0816 in Healthy Male Volunteers | ||
| NCT01651481 | Study to Evaluate the Pharmacokinetics and Safety of Singulair and Xyzal in Free Combination and Fixed-dose Combination | ||
| NCT03330327 | Molar Potency Study of HM12470 in Healthy Subjects | ||
| NCT04959305 | A Phase 2 Study to Explore the Dose of HCP1803 in Patients With Essential Hypertension | ||
| NCT07379333 | A Study to Evaluate Efficacy and Safety of HM11260C in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin | ||
| NCT05362110 | A Study to Evaluate Efficacy and Safety of HCP1803 in Patients With Essential Hypertension | ||
| NCT01775579 | Evaluating a Pharmacokinetic Drug Interaction Between Metformin Hydrochloride and Rosuvastatin Calcium | ||
| NCT01521455 | Therapeutic Equivalence Study of HCP0910 250/50 Mcg to Seretide 250 Diskus in Asthmatic Patients | ||
| NCT00979563 | Clinical Trial to Evaluate Safety and Tolerability of OratecanTM in Patients With Advanced Solid Malignancies | ||
| NCT02387554 | Pharmacokinetic Interaction Between HGP0904, HGP0608 and HGP1405 | ||
| NCT02941796 | Pharmacokinetics and Safety of HCP1105 and Co-administration of HGP0918, HGP0816 in Healthy Male Volunteers | ||
| NCT01806818 | Comparing Efficacy and Safety Between Eperisone a BID and a TID Regimen in Acute Low Back Pain Patients | ||
| NCT05845489 | Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION) | ||
| NCT05548543 | A Study to Evaluate the Pharmacokinetics and Safety Between HCP2202 and Co-administration of Each Component in Healthy Volunteers Under Fed Conditions | ||
| NCT01765478 | Safety,PK/PD, Food Effect Study of Orally Administered HM71224 in Healthy Adult Male Volunteers | ||
| NCT02075281 | Effect of LAPS-Exendin on Body Weight in Obese Population | ||
| NCT04076293 | Single Ascending Dose Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM15912(Sonefpeglutide) in Healthy Korean Subjects | ||
| NCT03826641 | A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1801 in Healthy Subjects | ||
| NCT06858397 | A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease | ||
| NCT00986843 | Clinical Trial to Evaluate Safety and Tolerability of OratecanTM in Patients With Advanced Solid Malignancies (Oratecan-102) | ||
| NCT01491217 | A Study of Oraxol® in Gastric Cancer Patients | ||
| NCT03089112 | Pharmacokinetic Drug Interactions Between HGP1607 and HGP1501 | ||
| NCT01463982 | Phase I of OratecanTM in Combination With Capecitabine in Patients With Advanced Solid Malignancies | ||
| NCT05407220 | A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1904 in Healthy Male Volunteers. | ||
| NCT04084197 | A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HIP1801 in Healthy Male Subjects. | ||
| NCT02294539 | Comparison of Effects Between Amlodipine and Hydrochlorothiazide in Combination With Losartan on 24-hr Central Blood Pressure in Hypertensive Patients | ||
| NCT05548387 | A Study to Evaluate the Pharmacokinetics and Safety Between HCP2202 and Co-administration of Each Component in Healthy Volunteers | ||
| NCT02712411 | Pharmacokinetics and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 in Healthy Male Volunteers | ||
| NCT01588145 | Phase I/II Trial to Evaluate Safety, Tolerability and Pharmacokinetic Profile of HM61713 in NSCLC Patients | ||
| NCT01688193 | Study to Evaluate and Compare Safety and Pharmacokinetics of the HCP1004 and VIMOVO 500/20mg in Healthy Korean Male | ||
| NCT00940680 | Efficacy/Safety of Amlodipine Plus Losartan Versus Losartan in Patients With Essential Hypertension | ||
| NCT03882112 | Food-effect on PK and PD of Single Oral Dose of HIP1601 in Healthy Male Subjects | ||
| NCT01093742 | A Study of HM10560A in Healthy Male Subject | ||
| NCT07449754 | Belvarafenib in Combination With Cobimetinib in Patients With Locally Advanced or Metastatic NRAS-Mutant Melanoma | ||
| NCT01013064 | A Study of HM10760A (Long-acting Erythropoietin (EPO)) in Healthy Korean Subjects | ||
| NCT04032782 | A First-in-Human, Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HM15136(Efpegerglucagon) in Healthy Subjects | ||
| NCT01491204 | Clinical Trial to Determine the Maximum Tolerated Dose and to Assess the Safety and Pharmacokinetic Profile of Oral Paclitaxel in Patients With Advanced Solid Cancer | ||
| NCT05191563 | A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination of HCP1904 and Co-Administration of RLD2001-2 and RLD2006 Tablets in Healthy Subjects. | ||
| NCT04762407 | A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1903 | ||
| NCT01455571 | Phase I Study to Determine the Maximum Tolerated Dose and to Assess the Safety and Pharmacokinetic Profile of HM781-36B in Patients With Advanced Solid Tumors | ||
| NCT02057172 | Glycaemic Control of Weekly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes | ||
| NCT04510415 | Olmutinib 600 mg QD in Patients With T790M-positive NSCLC After Treatment With an EGFR-TKI | ||
| NCT02302443 | A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12470 | ||
| NCT05737082 | A Study to Evaluate the Pharmacokinetics and Safety Between HCP2201 and Co-administration of Each Component in Healty Male Volunteers | ||
| NCT03372850 | Safety, Pharmacokinetics and Pharmacodynamics of the Two Esomeprazole Formulations | ||
| NCT04204629 | Food-effect on PK and PD of Single Oral Dose of HIP1601 in Healthy Subjects |
